A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

The Lancet

Volumn 371, Issue 9616, 2008, Pages 899-907

  Ormiston, John A ^a   Serruys, Patrick W ^b   Regar, Evelyn ^b   Dudek, Dariusz ^c   Thuesen, Leif ^d   Webster, Mark WI ^a   Onuma, Yoshinobu ^b   Garcia Garcia, Hector M ^e   McGreevy, Robert ^f   Veldhof, Susan ^f  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e CARDIALYSIS   (Netherlands)

^f ABBOTT VASCULAR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; POLYLACTIDE; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG BLOOD LEVEL; DRUG ELUTING STENT; DRUG TISSUE LEVEL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; ISCHEMIA; MALE; MULTICENTER STUDY; OPEN STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY; REVASCULARIZATION; TEACHING HOSPITAL; THROMBOSIS;

EID: 40649083620     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60415-8     Document Type: Article

References (28)

1. Mintz G., Popma J., Pichard A., et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94 (1996) 35-43
2. Serruys P., Kutryk M., and Ong A. Coronary-artery stents. N Engl J Med 354 (2006) 483-495
3. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
4. Finn A., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
5. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
6. Tamai H., Igaki K., Kyo E., et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102 (2000) 399-404
7. Erbel R., Di Mario C., Bartunek J., et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369 (2007) 1869-1875
8. Cutlip D., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
9. Bruining N., von Birgelen C., de Feyter P., et al. ECG-gated versus nongated three-dimensional intracoronary ultrasound analysis: implications for volumetric measurements. Cathet Cardiovasc Diagn 43 (1998) 254-260
10. von Birgelen C., de Vrey E., Mintz G., et al. ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation 96 (1997) 2944-2952
11. Nair A., Kuban B., Tuzcu E., Schoenhagen P., Nissen S., and Vince D. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106 (2002) 2200-2206
12. Nair A., Kuban B., Obuchowski N., and Vince D. Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data. Ultrasound Med Biol 27 (2001) 1319-1331
13. Nair A., Margolis M.P., Kuban B., and Vince D. Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroInterv 3 (2007) 113-120
14. Regar E., van Leeuwen A., and Serruys P. Optical coherence tomography in cardiovascular research. 1st edn. (2007), Informa Healthcare, London
15. Tanigawa J., Barlis P., and Mario C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroInterv 3 (2007) 128-136
16. Serruys P., Ong A., Piek J., et al. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial. EuroInterv 1 (2005) 58-65
17. Serruys P., Ruygrok P., Neuzner J., et al. A randomized comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial. EuroInterv 2 (2006) 286-294
18. Sousa J., Costa M., Abizaid A., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104 (2001) 2007-2011
19. Rensing B., Vos J., Smits P., et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22 (2001) 2125-2130
20. Silber S., Albertsson P., Aviles F., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
21. Smith Jr. S., Feldman T., Hirshfeld Jr. J., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) 156-175
22. Tanabe K., Serruys P., Degertekin M., et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111 (2005) 900-905
23. Stone G., Ellis S., Cox D., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
24. Grube E., Sonoda S., Ikeno F., et al. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation 109 (2004) 2168-2171
25. Costa R., Lansky A., Mintz G., et al. Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). Am J Cardiol 95 (2005) 113-116
26. Meredith I., Ormiston J., Whitbourn R., et al. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. EuroInterv 1 (2005) 157-164
27. Fajadet J., Wijns W., Laarman G., et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 114 (2006) 798-806
28. Tanimoto S., Serruys P., Thuesen L., et al. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 70 (2007) 515-523